Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026
Increase in Mycoplasma pneumoniae infections in 2024: experience of a tertiary-care hospital from Porto Alegre, Brazil.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sorio Guilherme Geraldo Lovato, Giannini Gabriela Luchiari Tumioto, Gorges Muriel, Perez Luiza Martinez, Klafke Renata Dortzbacher Feil, Martins Erik Menezes, Marinho Letícia Camargo, Flores Gabriela Pereira, da Silva Kawski Cristiane Tejada, Braga Andressa, Pizzi Jaysa, Arns Beatriz, Zavascki Alexandre Prehn
Аннотация
BACKGROUND: Mycoplasma pneumoniae infections declined globally during the COVID-19 pandemic but resurged in 2023, with no data from Latin America.
METHODS: We conducted a time-series analysis of patients tested with a multiplex PCR panel at a tertiary hospital in Brazil (April 2022-December 2024).
RESULTS: No cases were identified in 2022, two occurred in 2023 and 132 in 2024. Overall, 85% occurred in children; 68.2% were hospitalized; 18.9% required intensive care; and one patient died.
CONCLUSIONS: This is the first report of a postpandemic M. pneumoniae outbreak in a Latin American country, underscoring the need for improved surveillance.
METHODS: We conducted a time-series analysis of patients tested with a multiplex PCR panel at a tertiary hospital in Brazil (April 2022-December 2024).
RESULTS: No cases were identified in 2022, two occurred in 2023 and 132 in 2024. Overall, 85% occurred in children; 68.2% were hospitalized; 18.9% required intensive care; and one patient died.
CONCLUSIONS: This is the first report of a postpandemic M. pneumoniae outbreak in a Latin American country, underscoring the need for improved surveillance.